Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus

Lithium (Li) is the mainstay pharmacotherapeutic mood stabilizer in bipolar disorder. Its efficacious use is complicated by acute and chronic renal side effects, including nephrogenic diabetes insipidus (NDI) and progression to chronic kidney disease (CKD). The nuclear factor erythroid-derived 2–rel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Jobbagy, Soma, Vitturi, Dario A., Salvatore, Sonia R., Pires, Maria F., Rowart, Pascal, Emlet, David R., Ross, Mark, Hahn, Scott, St. Croix, Claudette, Wendell, Stacy G., Subramanya, Arohan R., Straub, Adam C., Tan, Roderick J., Schopfer, Francisco J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7030822/
https://ncbi.nlm.nih.gov/pubmed/31941842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.128578
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados